Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 32

Adult ID

Global ID

Investigative ID

HIV-STD-TB

Trainee

COVID
Interactive Session

74 - Clinical Trial Lessons Learned from COVID-19: What Worked and What Didn't

Friday, October 1, 2021
10:00 AM - 11:15 AM EDT

    Interactive Moderator(s)

  • LB

    Lindsey Baden, MD

    Attending Physician
    Brigham and Women's Hospital
    Boston, MA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Peter Marks, MD, PhD

    Director, Center of Biologics Evaluation and Research
    Food & Drug Administration
    Silver Spring, MD, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Panelist(s)

  • LD

    Lori Dodd, PhD

    Section Chief, Biostatistician
    Clinical Trials Research Section, Biostatistics Research Branch, Division of Clinical Research, NIAID
    Bethesda, MD, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Kara Chew, MD, MS

    Associate Professor
    David Geffen School of Medicine at UCLA

    Amgen (Individual(s) Involved: Self): Grant/Research Support; Merck Sharp & Dohme (Individual(s) Involved: Self): Grant/Research Support

  • Derek Angus, MD MPH, FRCP

    Chief Innovation Officer and Executive Vice President
    Critical Care Medicine
    UPMC
    Pittsburgh, PA, United States

    national institutes of health (Individual(s) Involved: Self): Grant/Research Support

  • AR

    Ana Maria Restrepo

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

Participants should be aware of the following financial/non-financial relationships:
Lindsey R. Baden, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Peter Marks, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Lori E. Dodd, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kara W. Chew, MD, MS: Amgen (Individual(s) Involved: Self): Grant/Research Support; Merck Sharp & Dohme (Individual(s) Involved: Self): Grant/Research Support
Derek C. Angus, MD MPH, FRCP: national institutes of health (Individual(s) Involved: Self): Grant/Research Support
Ana Maria Restrepo: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • discuss how clinical trial questions were prioritized during COVID-19
  • evaluate data from major adaptive/platform trials
  • assess lessons learned from COVID-19 trials to apply to future infectious disease outbreaks